At a glance
- Originator Pharmacia Corporation
- Class Antihyperlipidaemics; Benzopyrans
- Mechanism of Action Sterol O-acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 14 Jul 1999 No-Development-Reported for Hyperlipidaemia in USA (Unknown route)